Receptor tyrosine-protein kinase erbB-2 (435-443)

Receptor tyrosine-protein kinase erbB-2 (435-443) is a synthetic peptide fragment corresponding to amino acids 435 to 443 of the human erbB-2 (HER2/neu) protein. As a segment derived from the extracellular domain of this well-characterized receptor tyrosine kinase, it holds significant value in molecular biology and biochemical research. The sequence represents a functionally relevant epitope within the erbB-2 protein, which is widely recognized for its role in cell signaling pathways that regulate growth, differentiation, and survival. Researchers employ this peptide to probe the molecular mechanisms of receptor activation, study protein-protein interactions, and develop novel analytical assays targeting the HER2 axis.

Epitope mapping: The 435-443 region of the erbB-2 protein serves as a defined linear epitope, making it highly useful for antibody characterization and specificity studies. Scientists utilize this peptide to identify and validate monoclonal and polyclonal antibodies that recognize the extracellular domain of HER2/neu. By providing a well-defined target, the peptide supports the development of immunoassays and the refinement of antibody-based detection techniques, facilitating more precise interrogation of receptor status in various biological samples.

Signal transduction research: As a representative segment of the erbB-2 extracellular domain, this peptide enables detailed investigation into the molecular determinants of receptor function. Researchers can employ it in binding studies to elucidate how specific extracellular motifs contribute to ligand recognition, dimerization, or conformational changes that trigger intracellular signaling cascades. Such studies help clarify the structure-function relationships within the HER2/neu receptor family and advance understanding of receptor-mediated signaling events.

Peptide-based assay development: The defined sequence of erbB-2 (435-443) is leveraged in the design and calibration of peptide-based assays, including enzyme-linked immunosorbent assays (ELISA), surface plasmon resonance (SPR), and other biosensor platforms. By serving as a standard or capture reagent, the peptide enables quantitative and qualitative assessment of antibody binding, receptor-ligand interactions, or the presence of related biomolecules in complex mixtures. This contributes to the creation of robust, reproducible analytical tools for laboratory and industrial applications.

Protein interaction studies: The synthetic peptide corresponding to erbB-2 (435-443) is employed in affinity-based experiments to identify and characterize proteins or small molecules that interact with this region of the receptor. Such studies are instrumental in mapping extracellular binding partners, screening for inhibitory compounds, or elucidating mechanisms of receptor modulation. By isolating interactions specific to this epitope, researchers gain insights into the broader network of molecular associations governing HER2/neu activity.

Immunogenicity assessment: The peptide is also used as a model antigen in studies aimed at evaluating immunogenic responses to specific HER2/neu epitopes. By incorporating the 435-443 fragment into immunological assays, investigators can assess the capacity of immune cells or antibodies to recognize and respond to this region. These experiments are fundamental in understanding antigenicity, designing peptide-based probes, and supporting the development of research tools for immunological investigations centered on the HER2/neu system.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

3. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

5. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet